Skip to main content

Advertisement

Log in

Development and evaluation of film coated aceclofenac and chlorzoxazone tablet with enhanced dissolution rate

  • Original Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Out of many complications two major problems facing in formulation industry are poor solubility and short half-life of drugs which results into poor bioavailability after oral administration. Solid dosage forms are coated for a number of reasons, the most important of which is controlling the release profiles and bioavailability of the active ingredient. Thus the development of a significant dissolution procedure for drug products with limited water solubility has been a challenge to the pharmaceutical industry. Aceclofenac (Biopharmaceutical classification Class II drug) is a novel non-steroidal anti-inflammatory drugs (NSAIDs) having anti-inflammatory and analgesic properties, and is widely used in the treatment of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. The investigation revealed that there is no official dissolution medium available in the literature. The objective of present study is to formulate film coated tablet of Aceclofenac and Chlorzoxazone having short half-life by coating with hydroxyl propyl methyl cellulose (E5 LV). Then the formulated tablets were evaluated for its physicochemical properties and in vitro release studies. The incorporation of drugs into polymer matrices is considered a valid tool in order to optimize insufficient features of the drug molecule, like solubility, stability or toxic effects. In the present work, the incorporation of aceclofenac was performed in inert HPMC and there was no chemical interaction between the drug and polymers as concluded from the FTIR studies. In the present study, parameters such as solubility, medium pH, surfactant type, dissolution behavior of formulations, stability, and discriminatory effect of dissolution testing in different dissolution mediums were studied for the selection of a proper dissolution medium. The drug showed an enhanced release rate in the dissolution media containing pH 6.8 phosphate buffer, 900 ml with 0.5 % sodium lauryl sulphate at 75 rpm for 60 min and thus was chosen as the discriminating dissolution method for film coated aceclofenac formulation. It was found that greater than 80 % of the label amount is released over 60 min.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420

    Article  CAS  PubMed  Google Scholar 

  • Appa RB, Shivalingam MR, Kishore Reddy YV et al (2010) Formulation and evaluation of aceclofenac solid dispersions for dissolution rate enhancement. Int J Pharm Sci Drug Res 2:146–150

  • Ashraful Islam SM, Abuzar MS, Paul PK (2011) Validation of UV-spectrophotometric and RP-HPLC methods for the simultaneous analysis of paracetamol and aceclofenac in marketed tablets. Int J Pharm LIFE Sci 2:1267–1275

    Google Scholar 

  • Bajdik J, Pintye-Hódi K, Planinšek O et al (2004) Film coating as a method to enhance the preparation of tablets from dimenhydrinate crystals. Int J Pharm 269:393–401. doi:10.1016/j.ijpharm.2003.09.039

    Article  CAS  PubMed  Google Scholar 

  • Bhardwaj S, Jain V, Jat RC et al (2010) Formulation and evaluation of fast dissolving tablet of aceclofenac—ProQuest. Int J Drug Deliv 2:93–97

    Article  CAS  Google Scholar 

  • Dressman JB, Amidon GL, Reppas C, Shah VP (1998) Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 15:11–22

    Article  CAS  PubMed  Google Scholar 

  • FDA (1997) Guidance for industry: modified-release solid oral dosage forms

  • FIP (1977) Formulation and preparation of dosage forms. In: Proceedings of the 37th international congress of pharmaceutical sciences of F.I.P. held in The Hague, The Netherlands, September 5–9, 1977. Elsevier/North-Holland Biomedical Press

  • Ghosh S, Barik B (2010) Formulation and in vitro evaluation of once daily sustained release formulation of aceclofenac. Trop J Pharm Res. doi:10.4314/tjpr.v9i3.56288

    Google Scholar 

  • Harnby N, Hawkins AE, Vandame D (1987) The use of bulk density determination as a means of typifying the flow characteristics of loosely compacted powders under conditions of variable relative humidity. Chem Eng Sci 42:879–888. doi:10.1016/0009-2509(87)80046-5

    Article  CAS  Google Scholar 

  • Higuchi T (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–1149. doi:10.1002/jps.2600521210

    Article  CAS  PubMed  Google Scholar 

  • Islam MS, Reza S, Rahman H (2010) In vitro release kinetics study of diltiazem hydrochloride from wax and kollidon sr based matrix tablets. Iran J Pharm Res 11:101–108

  • Jinno J, Oh DM, Crison JR, Amidon GL (2000) Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J Pharm Sci 89:268–274. doi:10.1002/(SICI)1520-6017(200002)89:2<268:AID-JPS14>3.0.CO;2-F

    Article  CAS  PubMed  Google Scholar 

  • Kabir AKL, Halder S, Shuma ML, Rouf ASS (2012) Formulation development and in vitro evaluation of drug release kinetics from sustained release aceclofenac matrix tablets using hydroxypropyl methyl cellulose. Dhaka Univ J Pharm Sci 11:37–43

  • Kar RK, Mohapata S, Barik BB (2009) Design and characterization of controlled release matrix tablets of zidovudine. Asian J Pharm Clin Res 2:54–61

    CAS  Google Scholar 

  • Legrand E (2004) Aceclofenac in the management of inflammatory pain. Expert Opin Pharmacother 5:1347–1357. doi:10.1517/14656566.5.6.1347

    Article  CAS  PubMed  Google Scholar 

  • Pillay V, Fassihi R (1998) Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J Control Release 55:45–55. doi:10.1016/S0168-3659(98)00022-4

    Article  CAS  PubMed  Google Scholar 

  • Shah VP, Konecny JJ, Everett RL et al (1989) In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm Res 6:612–618

    Article  CAS  PubMed  Google Scholar 

  • Sinko PJ (2006) Martin’s physical pharmacy and pharmaceutical sciences: physical chemical and biopharmaceutical principles in the pharmaceutical sciences. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Soni NM, Bhitre DMJ, Trivedi P (2013) Enhancement of dissolution of aceclofenac film coated tablet by micronisation technique. Int J Pharm Res Sch 2:47–52

    Google Scholar 

  • Umarunnisha AM, Palanichamy S, Rajesh M et al (2010) Formulation and evaluation of matrix tablets of famotidine using hydrophilic polymer. Arch Appl Sci Res 2:212–220

Download references

Acknowledgments

All the authors (S. Jain, A. Jain, Ashay Jain, S. Shrivastava, A. K. Jain) declare that they have no conflict of interest. This article does not contain any studies with human and animal subjects performed by any of the authors. The authors are thankful to the Rajiv Gandhi Technichal University, Bhopal (M.P.) and Bhagyoday Tirth Pharmacy College Sagar (M.P.) for providing the necessary infrastructure and facilities. Shaila Jain is grateful for the fellowship provided by the AICTE, India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaila Jain M.Pharm.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, S., Jain, A., Jain, A. et al. Development and evaluation of film coated aceclofenac and chlorzoxazone tablet with enhanced dissolution rate. Journal of Pharmaceutical Investigation 46, 467–474 (2016). https://doi.org/10.1007/s40005-016-0238-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-016-0238-z

Keywords

Navigation